Amgen stock pops after company agrees to buy Celgene’s blockbuster anti-inflammatory drug Otezla
August 26, 2019 at 12:53 PM EDT
Shares of Amgen Inc. popped 3% Monday after the company said it would buy psoriasis drug Otezla from Celgene Corp.
